PBE vs IFV
Comparison between INVESCO BIOTECHNOLOGY & GENOME ETF (PBE, ETF) and FIRST TRUST DORSEY WRIGHT INTERNATIONAL FOCUS 5 ETF (IFV, ETF).
5-Year PerformanceIFV has outperformed PBE, delivering a return of +4.4% compared to +2.0%
PBE vs IFV - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Net Assets
Winner
PBE
$259M
IFV
$259M
Expense Ratio
Winner
PBE
0.58%
IFV
1.14%
Max Drawdown
Winner
PBE
45.69%
IFV
51.24%
Sharpe Ratio
Winner
PBE
1.35
IFV
1.19
5Y Beta
PBE
0.76
Winner
IFV
0.68
P/E Ratio
PBE
36.34
IFV
N/A
Forward P/E
PBE
19.88
IFV
N/A
5Y Dividends CAGR
Winner
PBE
98.81%
IFV
7.76%
5Y EPS CAGR
PBE
12.51%
IFV
N/A
Debt to Equity
PBE
54.69%
IFV
N/A
P/S Ratio
PBE
5.10
IFV
N/A
P/B Ratio
PBE
4.58
IFV
N/A
PBE vs IFV - Holdings Comparison
PBE and IFV have 0 common holdings. Overlap is 0.00%
PBE's top 25 holdings weight is 89.66%. IFV's top 25 holdings weight is 99.93%.
| Rank | PBE | IFV |
|---|---|---|
| #1 | ILLUMINA INC (ILMN) - 6.77% | FIRST TRUST ASIAPAC EX-JPN ALPHADEX® ETF (FPA) - 23.17% |
| #2 | UNITED THERAPEUTICS CORP (UTHR) - 5.84% | FIRST TRUST EUROZONE ALPHADEX® ETF (FEUZ) - 19.76% |
| #3 | BIOGEN INC (BIIB) - 4.95% | FIRST TRUST GERMANY ALPHADEX® ETF (FGM) - 19.56% |
| #4 | INCYTE CORP (INCY) - 4.67% | FIRST TRUST EUROPE ALPHADEX® ETF (FEP) - 19.48% |
| #5 | GILEAD SCIENCES INC (GILD) - 4.42% | FIRST TRUST CHINA ALPHADEX® ETF (FCA) - 17.96% |
| #6 | ALNYLAM PHARMACEUTICALS INC (ALNY) - 4.39% | N/A |
| #7 | AMGEN INC (AMGN) - 4.38% | N/A |
| #8 | REGENERON PHARMACEUTICALS INC (REGN) - 4.00% | N/A |
| #9 | VERACYTE INC (VCYT) - 3.74% | N/A |
| #10 | CATALYST PHARMACEUTICALS INC (CPRX) - 3.61% | N/A |
| #11 | TG THERAPEUTICS INC (TGTX) - 3.35% | N/A |
| #12 | ROYALTY PHARMA PLC CLASS A (RPRX) - 3.32% | N/A |
| #13 | NEUROCRINE BIOSCIENCES INC (NBIX) - 3.30% | N/A |
| #14 | CAREDX INC (CDNA) - 3.20% | N/A |
| #15 | ARROWHEAD PHARMACEUTICALS INC (ARWR) - 3.10% | N/A |
| #16 | BIOCRYST PHARMACEUTICALS INC (BCRX) - 3.06% | N/A |
| #17 | EXELIXIS INC (EXEL) - 3.00% | N/A |
| #18 | PROTAGONIST THERAPEUTICS INC (PTGX) - 2.98% | N/A |
| #19 | PTC THERAPEUTICS INC (PTCT) - 2.76% | N/A |
| #20 | HALOZYME THERAPEUTICS INC (HALO) - 2.63% | N/A |
| #21 | VERICEL CORP (VCEL) - 2.51% | N/A |
| #22 | REPLIGEN CORP (RGEN) - 2.51% | N/A |
| #23 | BIO-TECHNE CORP (TECH) - 2.41% | N/A |
| #24 | IONIS PHARMACEUTICALS INC (IONS) - 2.38% | N/A |
| #25 | BIOMARIN PHARMACEUTICAL INC (BMRN) - 2.38% | N/A |
| Total Holdings | 33 | 5 |
PBE vs IFV - Historical Returns
Returns include dividend reinvestment.
1M
Winner
PBE
+1.34%
IFV
-1.27%
3M
Winner
PBE
+10.51%
IFV
+8.12%
6M
PBE
+5.02%
Winner
IFV
+13.82%
1Y
Winner
PBE
+31.39%
IFV
+25.40%
5Y(CAGR)
PBE
+1.98%
Winner
IFV
+4.44%
10Y(CAGR)
Winner
PBE
+8.47%
IFV
+7.40%
Max(CAGR)
Winner
PBE
+8.90%
IFV
+4.66%
PBE vs IFV - Annual Returns (2005 - 2026)
Returns include dividend reinvestment.
| Year | PBE | IFV |
|---|---|---|
| 2026 | +2.24% | +9.98% |
| 2025 | +23.76% | +32.24% |
| 2024 | -0.05% | +1.00% |
| 2023 | +4.60% | +22.61% |
| 2022 | -11.11% | -25.67% |
| 2021 | +1.21% | +4.37% |
| 2020 | +25.68% | +4.57% |
| 2019 | +18.35% | +24.45% |
| 2018 | -2.62% | -21.77% |
| 2017 | +20.54% | +30.59% |
| 2016 | -20.66% | -1.59% |
| 2015 | +1.36% | +0.43% |
| 2014 | +36.45% | -9.93% |
| 2013 | +57.53% | N/A |
| 2012 | +13.17% | N/A |
| 2011 | -7.24% | N/A |
| 2010 | +29.99% | N/A |
| 2009 | +19.16% | N/A |
| 2008 | -25.84% | N/A |
| 2007 | +6.24% | N/A |
| 2006 | +0.45% | N/A |
| 2005 | +17.45% | N/A |
PBE vs IFV Drawdown Comparison
The maximum drawdown for PBE was -45.69%, occurring on Mar 9, 2009. Recovery took 644 trading sessions.
The maximum drawdown for IFV was -48.88%, occurring on Mar 18, 2020. Recovery took 740 trading sessions.
The current PBE drawdown is -1.80%. The current IFV drawdown is -2.49%.
| Rank | PBE | IFV |
|---|---|---|
| #1 | -45.69% Oct 15, 2007 - May 6, 2010 | -48.88% Jan 26, 2018 - Jan 5, 2021 |
| #2 | -44.56% Jul 17, 2015 - Jul 20, 2020 | -35.32% Jun 8, 2021 - Jun 26, 2025 |
| #3 | -37.84% Feb 8, 2021 - Nov 26, 2025 | -28.10% May 15, 2015 - May 16, 2017 |
| #4 | -35.71% May 6, 2010 - Apr 2, 2013 | -14.62% Jul 23, 2014 - Apr 9, 2015 |
| #5 | -21.12% Feb 27, 2006 - Apr 23, 2007 | -12.57% Feb 25, 2026 - May 6, 2026 |
| #6 | -18.86% Feb 24, 2014 - Aug 25, 2014 | -8.11% Feb 16, 2021 - May 28, 2021 |
| #7 | -14.38% Jul 20, 2020 - Nov 27, 2020 | -7.18% May 16, 2017 - Jul 19, 2017 |
| #8 | -11.73% Jan 7, 2026 - Mar 27, 2026 | -6.00% May 11, 2026 - Jun 10, 2026 |
| #9 | -10.65% Mar 19, 2015 - Jun 18, 2015 | -5.73% Nov 12, 2025 - Dec 19, 2025 |
| #10 | -10.08% Sep 12, 2005 - Nov 17, 2005 | -4.72% Jul 23, 2025 - Aug 12, 2025 |
| #11 | -9.07% Apr 25, 2007 - Sep 26, 2007 | -4.26% Jan 21, 2021 - Feb 3, 2021 |
| #12 | -8.60% Aug 29, 2014 - Oct 23, 2014 | -3.56% Aug 22, 2025 - Sep 30, 2025 |
| #13 | -7.84% May 28, 2013 - Jul 5, 2013 | -3.15% Nov 24, 2017 - Dec 27, 2017 |
| #14 | -7.21% Nov 29, 2013 - Jan 7, 2014 | -3.10% Aug 7, 2017 - Sep 1, 2017 |
| #15 | -6.59% Oct 2, 2013 - Oct 24, 2013 | -2.95% Oct 6, 2025 - Nov 12, 2025 |
Correlation
Correlation between PBE and IFV is 0.83 which considered as a strong positive correlation - the stocks tend to move together.
0.83
-101
Dividend Comparison (2009 - 2026)
PBE vs IFV dividend yield comparison.
| Year | PBE | IFV |
|---|---|---|
| 2026 | 0.10% | 0.03% |
| 2025 | 1.00% | 1.95% |
| 2024 | 0.05% | 2.31% |
| 2023 | 0.02% | 2.88% |
| 2022 | 0.00% | 3.79% |
| 2021 | 0.00% | 1.04% |
| 2020 | 0.04% | 1.53% |
| 2019 | 0.00% | 2.91% |
| 2018 | 0.00% | 1.86% |
| 2017 | 0.57% | 1.43% |
| 2016 | 0.38% | 1.10% |
| 2015 | 1.12% | 1.52% |
| 2014 | 0.55% | 0.21% |
| 2009 | 0.45% | 0.00% |
Select Stocks to Compare
Popular: PBE vs SPYIFV vs SPY
More Comparisons
Compare with similar stocks